Sanofi
Lilly’s John Lechleiter elected as PhRMA Board chairman
April 17, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, John Lechleiter, Pfizer, Sanofi, lilly
John Lechleiter, chairman, president and chief executive of Lilly has been elected chairman of the Pharmaceutical Research and Manufacturers of …
MSI appoints new partner
April 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, Sanofi, appointment
Pharma consultancy firm MSI has announced the appointment of a new partner. Steve Mather takes up this senior position with …
FDA grants priority review for Sanofi cancer drug
April 5, 2012Research and Development, Sales and Marketing Erbitux, FDA, Regeneron, Sanofi, Zaltrap, colorectal cancer, prostate cancer
The FDA has granted Sanofi and partner Regeneron priority review for their colorectal cancer drug Zaltrap. Zaltrap (aflibercept) is seeking a …
Sanofi sets up cholesterol drug showdown with Amgen
March 27, 2012Research and Development, Sales and Marketing Amgen, BMS, LDL, Lipitor, Merck, Regeneron, Sanofi
Sanofi and Amgen have posted results for their new injectable cholesterol drugs within 24 hours of each other. Both drugs …
Dismay as Sanofi announces UK plant closure
March 15, 2012Manufacturing and Production, Sales and Marketing Plavix, Sanofi, job losses, manufacturing
Sanofi has decided to close down a manufacturing facility in the North East of the UK with the loss of …
Sanofi’s new diabetes device: worth the price?
March 12, 2012Medical Communications NHS, Sanofi, app, diabetes, iBGStar, smartphone
Sanofi launched its new iPhone and iPod Touch blood sugar monitor to much fanfare this week, but its high price …
Sanofi launches iPhone and iPod glucose monitor in the UK
March 12, 2012Medical Communications, Sales and Marketing BGStar, Sanofi, diabetes, iPod, iphone
Sanofi has launched a new diabetes device in the UK to help patients monitor their blood sugar levels from their …
inVentiv appoints former Quintiles man Mark Archer
March 9, 2012Business Services, Medical Communications, Sales and Marketing Merck, Quintiles, Roche, Sanofi, inVentiv
Pharma consultants inVentiv Health has appointed Mark as its new senior vice president of European operations and development for inVentiv …
Former Bayer man becomes senior VP of Sanofi’s Asia region
March 5, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Asia, Bayer, Sanofi
Sanofi has appointed Jean-Luc Lowinski as its new senior vice president of the Asia region, effective from 1 May. Jean-Luc …
EMA confirms verdict on Ben Venue facility
February 28, 2012Manufacturing and Production Ben Venue, CHMP, EMA, Sanofi
The European Medicines Agency has officially removed Ben Venue Laboratories’ troubled Bedford facility as an approved location for the manufacture …
EMA accepts Genzyme MS drug for review
February 24, 2012Research and Development, Sales and Marketing EMA, Genzyme, Sanofi, teriflunomide
The European Medicines Agency has accepted Genzyme’s application for its multiple sclerosis pill teriflunomide. Genzyme, which is wholly owned by …
Genzyme to close UK site
February 24, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, UK, job cuts
Genzyme will close its Cambridge R&D site by the end of the year, with a loss of around 60 jobs. …
Diabetes – the battle for control
February 15, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Novo Nordisk, Sanofi, Victoza, degludec, diabetes
This year marks the 90th anniversary of the first ever successful use of insulin to treat patients with type I …
NICE rejects Sanofi’s Jevtana
January 12, 2012Sales and Marketing Jevtana, NICE, Sanofi, Zytiga
NICE is not recommending Sanofi’s prostate cancer drug Jevtana due to its high cost and questions over its safety. In …
Sanofi to collaborate with UCSF on diabetes research
January 11, 2012Research and Development RNA interference, Sanofi, UCSF, academic alliance, diabetes
The University of California, San Francisco (UCSF) and Sanofi are to launch a new collaboration in diabetes research, focusing on …
Latest content
Five Facts about cardiovascular disease
